DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 15 Jul · 09:04 IST

Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has submitted a routine compliance certificate to the stock exchanges (NSE and BSE) for the quarter ended June 30, 2025. The certificate was issued by KFin Technologies Limited, the company's Registrar and Share Transfer Agent, as required under SEBI's Depositories and Participants Regulations, 2018. This is a standard quarterly regulatory filing that confirms the proper handling of share-related activities such as dematerialisation and transfer of shares during the quarter. The communication was signed by M. Satish Choudhury, Company Secretary and Compliance Officer, on July 15, 2025.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or stock price. It simply confirms that the company's registrar fulfilled its share-related duties during the quarter and is part of normal corporate governance disclosures.